Ezh2, A NOVEL TARGET IN TREATMENT OF MEDULLOBLASTOMA

被引：0
|
作者：
Ricke, Brandon [1 ]
Shah, Kushal [1 ]
Salacz, Michael [1 ]
Camarata, Paul [1 ]
Lovick, Darren [2 ]
Peng, Warner [1 ]
Dolatkhah, Roya [1 ]
Sanaat, Zohreh [1 ]
Kimura, Kyle [1 ]
Bi, Danse [1 ]
Taylor, Sarah [1 ]
Esfandyari, Tuba [1 ]
Farassati, Faris [1 ]
机构：
[1] Univ Kansas, Sch Med, Kansas City, KS USA
[2] Univ Missouri, Sch Med, St Lukes Hosp, Kansas City, KS USA
来源：
NEURO-ONCOLOGY | 2015年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TR-01
引用
收藏
页码：36 / 36
页数：1
相关论文
共 50 条
  • [41] Verification of EZH2 as a druggable target in metastatic uveal melanoma
    Jin, Bei
    Zhang, Ping
    Zou, Hailin
    Ye, Huijing
    Wang, Yun
    Zhang, Jing
    Yang, Huasheng
    Pan, Jingxuan
    MOLECULAR CANCER, 2020, 19 (01)
  • [42] Histone Methyltransferase EZH2: A Therapeutic Target for Ovarian Cancer
    Jones, Bayley A.
    Varambally, Sooryanarayana
    Arend, Rebecca C.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (03) : 591 - 602
  • [43] Role of the EZH2 histone methyltransferase as a therapeutic target in cancer
    Italiano, Antoine
    PHARMACOLOGY & THERAPEUTICS, 2016, 165 : 26 - 31
  • [44] Verification of EZH2 as a druggable target in metastatic uveal melanoma
    Bei Jin
    Ping Zhang
    Hailin Zou
    Huijing Ye
    Yun Wang
    Jing Zhang
    Huasheng Yang
    Jingxuan Pan
    Molecular Cancer, 19
  • [45] Exploring the role of EZH2 (PRC2) as epigenetic target
    Aier, Imlimaong
    Raj, Utkarsh
    2016 INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND SYSTEMS BIOLOGY (BSB), 2016,
  • [46] EZH2 Expression in Rhabdomyosarcoma: A Potential Biomarker and Therapeutic Target
    Wang, Qian
    Shapiro, Kate
    Lu, Yong
    Shroyer, Kenneth
    Hwang, Sonya
    LABORATORY INVESTIGATION, 2019, 99
  • [47] EZH2 as a therapeutic target in glioblastoma: a cellular and molecular study
    de la Rosa, Javier
    Iraburu, Marta
    Gallo-Oller, Gabriel
    Urdiciain, Alejandro
    Fan, Xing
    Shahi, Mehdi H.
    Melendez, Barbara
    Rey, Juan A.
    Idoate, Miguel A.
    Castresana, Javier S.
    CANCER RESEARCH, 2017, 77
  • [48] EZH2 Expression in Rhabdomyosarcoma: A Potential Biomarker and Therapeutic Target
    Wang, Qian
    Shapiro, Kate
    Lu, Yong
    Shroyer, Kenneth
    Hwang, Sonya
    MODERN PATHOLOGY, 2019, 32
  • [49] EZH2, a potential therapeutic target in Merkel cell carcinoma
    Durand, M.
    Mouchard, A.
    Esnault, C.
    Samimi, M.
    Kervarrec, T.
    Touze, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (10) : S191 - S191
  • [50] A novel selective EZH2 inhibitor exhibits anti-tumor activity in lymphoma with EZH2 activating mutations
    Creasy, Caretha L.
    McCabe, Michael T.
    Korenchuk, Susan
    Diaz, Elsie
    Ott, Heidi
    Thompson, Christine S.
    Ganji, Gopi
    Gorman, Shelby A.
    LaFrance, Louis V.
    Brandt, Martin
    McHugh, Charles
    Verma, Sharad K.
    Tummino, Peter J.
    CANCER RESEARCH, 2012, 72
12345